GIST肝転移のイマチニブ2次耐性例に術中RFAおよび肝切除術を施行した1例

症例は80歳,女性.残胃のgastrointestinal stromal tumor(以下,GIST)にて手術後,外来にて施行したCTにて多発性肝転移を認めたためイマチニブ投与を開始.奏効しPRが持続していたが,4カ所で肝転移の再燃を認めるようになったため肝部分切除および術中radiofrequency ablationを行い良好な結果を得た.再発GISTに対する治療はイマチニブが第1選択だが,2次耐性例に対しては治療法の選択に苦慮することが多いが,積極的な外科的介入の有用性が示唆された....

Full description

Saved in:
Bibliographic Details
Published in日本臨床外科学会雑誌 Vol. 69; no. 11; pp. 2952 - 2955
Main Authors 王子, 裕東, 坂元, 克考, 上原, 正弘, 馬場, 慎司, 玉木, 一路, 間中, 大
Format Journal Article
LanguageJapanese
Published 日本臨床外科学会 2008
Subjects
Online AccessGet full text
ISSN1345-2843
1882-5133
DOI10.3919/jjsa.69.2952

Cover

Abstract 症例は80歳,女性.残胃のgastrointestinal stromal tumor(以下,GIST)にて手術後,外来にて施行したCTにて多発性肝転移を認めたためイマチニブ投与を開始.奏効しPRが持続していたが,4カ所で肝転移の再燃を認めるようになったため肝部分切除および術中radiofrequency ablationを行い良好な結果を得た.再発GISTに対する治療はイマチニブが第1選択だが,2次耐性例に対しては治療法の選択に苦慮することが多いが,積極的な外科的介入の有用性が示唆された.
AbstractList 症例は80歳,女性.残胃のgastrointestinal stromal tumor(以下,GIST)にて手術後,外来にて施行したCTにて多発性肝転移を認めたためイマチニブ投与を開始.奏効しPRが持続していたが,4カ所で肝転移の再燃を認めるようになったため肝部分切除および術中radiofrequency ablationを行い良好な結果を得た.再発GISTに対する治療はイマチニブが第1選択だが,2次耐性例に対しては治療法の選択に苦慮することが多いが,積極的な外科的介入の有用性が示唆された.
Author 坂元, 克考
馬場, 慎司
玉木, 一路
上原, 正弘
王子, 裕東
間中, 大
Author_xml – sequence: 1
  fullname: 王子, 裕東
  organization: 京都桂病院外科
– sequence: 1
  fullname: 坂元, 克考
  organization: 京都桂病院外科
– sequence: 1
  fullname: 上原, 正弘
  organization: 京都桂病院外科
– sequence: 1
  fullname: 馬場, 慎司
  organization: 京都桂病院外科
– sequence: 1
  fullname: 玉木, 一路
  organization: 京都桂病院外科
– sequence: 1
  fullname: 間中, 大
  organization: 京都桂病院外科
BookMark eNo9kM1Kw0AUhQepYK3d-Rqp85NJMstSbC0UBK3rOEkm2lCrJN24a5KFxboQhYoLlUihC382boSiLzO1xrcwxeJdnHvg41y4ZxXkOscdAcA6giXCENvwvICXNFbCjOIlkEeGgRWKCMllnqhUwYZKVkAxCFoWhDgbCmke7Nfqu800uksnj9_jiQxfZTSS8b2MQxkPZDzEs-ck7V3OeuPp50CGT2lyPX1_2amWZXguo74M37LwV__s53aUIRldzYYfaXIhwxsZPqAsswaWXd4ORHGxC2CvutmsbCmN7Vq9Um4oHqYIKowIQ7iMEZ1rKmfZDxgamNsUcsSZBXXiatxSNVfTdeQI4VCHEuEYQrU5ppYgBVD5u-sFXX4gzBO_dcT9U5P73ZbdFua8HlNjJkILnff0T-1D7pseJ7-w1oCa
ContentType Journal Article
Copyright 2008 日本臨床外科学会
Copyright_xml – notice: 2008 日本臨床外科学会
DOI 10.3919/jjsa.69.2952
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 1882-5133
EndPage 2955
ExternalDocumentID article_jjsa_69_11_69_11_2952_article_char_ja
GroupedDBID 123
2WC
ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
RJT
ID FETCH-LOGICAL-j2510-93e8ef9937a64a99522082ac50a1a9b073f6ab46f6771deed5d53ed8e4ca25be3
ISSN 1345-2843
IngestDate Wed Sep 03 06:20:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 11
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2510-93e8ef9937a64a99522082ac50a1a9b073f6ab46f6771deed5d53ed8e4ca25be3
OpenAccessLink https://www.jstage.jst.go.jp/article/jjsa/69/11/69_11_2952/_article/-char/ja
PageCount 4
ParticipantIDs jstage_primary_article_jjsa_69_11_69_11_2952_article_char_ja
PublicationCentury 2000
PublicationDate 20080000
PublicationDateYYYYMMDD 2008-01-01
PublicationDate_xml – year: 2008
  text: 20080000
PublicationDecade 2000
PublicationTitle 日本臨床外科学会雑誌
PublicationTitleAlternate 日臨外会誌
PublicationYear 2008
Publisher 日本臨床外科学会
Publisher_xml – name: 日本臨床外科学会
References 8) Demetri GD, Benjamin RS, Blanke CD, et al : NCCN Task Force report : management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw (Suppl 2) : S1-29 ; quiz S30, 2007
3) 西田俊朗:【新しい癌の標的療法】GISTに対する分子標的治療法.Biother 18:519-526,2004
6) 神田達夫,大橋 学,松本 淳他:【GIST(gastrointestinal stromal tumor)】GISTに対するイマチニブ治療.臨消内科 20:1301-1308,2005
5) Verweij J, Casali P, Zalcberg J, et al : Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib : randomised trial. Lancet 364 : 1127-1134, 2004
7) Heinrich MC, Corless CL, Demetri GD, et al : Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21 : 4342-4349, 2003
2) Demetri G, von Mehren M, Blanke C, et al : Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347 : 472-480, 2002
12) Rutkowski P, Nowecki Z, Nyckowski P, et al : Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate. J Surg Oncol 93 : 304-311, 2006
11) Raut C, Posner M, Desai J, et al : Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol 24 : 2325-2331, 2006
14) Hasegawa J, Kanda T, Hirota S, et al : Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy. Int J Clin Oncol 12 : 212-217, 2007
13) 佐藤龍一郎,及川昌也,片寄 友他:イマチニブ投与後に切除しえた胃原発gastrointestinal stromal tumor多発肝転移の1例.日消外会誌 40:427-432,2007
10) 神田達夫,廣田誠一,神谷欣志他:GIST診断と治療の問題点 転移・再発性GISTに対するイマチニブ治療―耐性発現とその対策.日消外会誌 38:986,2005
4) Heinrich M, Corless C, Blanke C, et al : Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol 24 : 4764-4774, 2006
9) Gronchi A, Fiore M, Miselli F, et al : Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST. Ann Surg 245 : 341-346, 2007
1) DeMatteo R, Lewis JJ, Leung D, et al : Two hundred gastrointestinal stromal tumors : recurrence patterns and prognostic factors for survival. Ann Surg 231 : 51-58, 2000
References_xml – reference: 10) 神田達夫,廣田誠一,神谷欣志他:GIST診断と治療の問題点 転移・再発性GISTに対するイマチニブ治療―耐性発現とその対策.日消外会誌 38:986,2005
– reference: 14) Hasegawa J, Kanda T, Hirota S, et al : Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy. Int J Clin Oncol 12 : 212-217, 2007
– reference: 11) Raut C, Posner M, Desai J, et al : Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol 24 : 2325-2331, 2006
– reference: 6) 神田達夫,大橋 学,松本 淳他:【GIST(gastrointestinal stromal tumor)】GISTに対するイマチニブ治療.臨消内科 20:1301-1308,2005
– reference: 9) Gronchi A, Fiore M, Miselli F, et al : Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST. Ann Surg 245 : 341-346, 2007
– reference: 3) 西田俊朗:【新しい癌の標的療法】GISTに対する分子標的治療法.Biother 18:519-526,2004
– reference: 1) DeMatteo R, Lewis JJ, Leung D, et al : Two hundred gastrointestinal stromal tumors : recurrence patterns and prognostic factors for survival. Ann Surg 231 : 51-58, 2000
– reference: 2) Demetri G, von Mehren M, Blanke C, et al : Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347 : 472-480, 2002
– reference: 7) Heinrich MC, Corless CL, Demetri GD, et al : Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21 : 4342-4349, 2003
– reference: 4) Heinrich M, Corless C, Blanke C, et al : Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol 24 : 4764-4774, 2006
– reference: 12) Rutkowski P, Nowecki Z, Nyckowski P, et al : Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate. J Surg Oncol 93 : 304-311, 2006
– reference: 13) 佐藤龍一郎,及川昌也,片寄 友他:イマチニブ投与後に切除しえた胃原発gastrointestinal stromal tumor多発肝転移の1例.日消外会誌 40:427-432,2007
– reference: 5) Verweij J, Casali P, Zalcberg J, et al : Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib : randomised trial. Lancet 364 : 1127-1134, 2004
– reference: 8) Demetri GD, Benjamin RS, Blanke CD, et al : NCCN Task Force report : management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw (Suppl 2) : S1-29 ; quiz S30, 2007
SSID ssib002222505
ssib029852155
ssib039893138
ssib043658141
ssib058493876
ssj0061900
ssib000940327
ssib002822084
ssib002484630
ssib002484631
Score 1.721093
Snippet 症例は80歳,女性.残胃のgastrointestinal stromal tumor(以下,GIST)にて手術後,外来にて施行したCTにて多発性肝転移を認めたためイマチニブ投与を開始.奏効しPRが持続していたが,4カ所で肝転移の再燃を認めるようになったため肝部分切除および術中radiofrequency...
SourceID jstage
SourceType Publisher
StartPage 2952
SubjectTerms 2次耐性
gastrointestinal stromal tumor
イマチニブ
Title GIST肝転移のイマチニブ2次耐性例に術中RFAおよび肝切除術を施行した1例
URI https://www.jstage.jst.go.jp/article/jjsa/69/11/69_11_2952/_article/-char/ja
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本臨床外科学会雑誌, 2008, Vol.69(11), pp.2952-2955
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV29b9QwFI-qsrAgECC-1QEPDDmS2E5siSW5y1FAIAGt1O3I1w03FATtwtTcDVSUAYFUxACoqFIHPhYWpAr-mZRy_Be8ZyeXVOpAgSV6eX7v-fk5iX_Psh3DuBiJWHi0H5tekvVN5lnSFDJNTcAKXgLvlpepxZg3b7mz8-z6Al-Ymr7UWLW0vBS3ksf77iv5m14FHvQr7pI9QM9OjAIDaOhfuEIPw_WP-vjqtbtzJBREOER2kAgC4jsk9IjvIR1SAIrEDxXhEJ8pghIZlgSUlkRQFbmg7xK_TXxbmcaFEMgBAoyGjARhJQ2mA5QBSUlVEdCdO12_LBV-WbEQJSegDXc58gXYlERK5dzElNKSyhPpkqBTFol2aUd6FdG1Jz41cbbShDBwRbSxPaGqzBdYceAr5zjWChXogElbcTrEd5XNNpG-ci5QReABaE0mlVFJ6FAoJYgSPK1KDKKo6-2QwK7lOTKgXdhwjrFW8vomKGMtaC2v4qndhIpkV8u7ykOqWgEeilpeouPYUPDHIgGr5IXSRytdsLhnmkdMXsn_FbDGIEcZNwGW6BZlmoeZFv7rpzky6p_oVF8AuznOSX3ucImZ4JbvNx5TaeNxtoPBo6jlylatteeE8_L96aFYz5WQlJZXlO9VpbgLsTeAVOiQ43k2rt69cbuRSUhmUac5M-EguG8gUQDajUxZ3-_Zwu1Y9ZZtRwrAtfWWbSoB19v1UMUoIHe7ziQAxksqENlrEOgCztYHFJSh1ntuMB6Xm9EA3DuALLBaQapA7dxR40iZjc74uvHHjKlBdNy4h5-V8fDNePv9z63tIv9cDDeL0dtilBejtWK07ux-3BivPN9d2dr5vlbkH8YbL3e-foLXvsifFsPVIv8Cyj9Wn_x6vQlFxfDF7vq38cazIn9V5O9s0DlhzHfDufasWf6IxRxA-mOZkmYi62MmE7kskuA3xMqJEm5FdiRjQAl9N4qZ23ehZ1JA3TzlNEtFxpLI4XFGTxrTi_cXs1PGDJeCOalLWd_hTCSpsPpWgod4Zg6NAUWfNq7ogPQe6NN2egd6Os78m_pZ47BeD4ZTrOeM6aWHy9l5SDqW4gvqcfsNykvtxg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GIST%E8%82%9D%E8%BB%A2%E7%A7%BB%E3%81%AE%E3%82%A4%E3%83%9E%E3%83%81%E3%83%8B%E3%83%962%E6%AC%A1%E8%80%90%E6%80%A7%E4%BE%8B%E3%81%AB%E8%A1%93%E4%B8%ADRFA%E3%81%8A%E3%82%88%E3%81%B3%E8%82%9D%E5%88%87%E9%99%A4%E8%A1%93%E3%82%92%E6%96%BD%E8%A1%8C%E3%81%97%E3%81%9F1%E4%BE%8B&rft.jtitle=%E6%97%A5%E6%9C%AC%E8%87%A8%E5%BA%8A%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E7%8E%8B%E5%AD%90%2C+%E8%A3%95%E6%9D%B1&rft.au=%E5%9D%82%E5%85%83%2C+%E5%85%8B%E8%80%83&rft.au=%E4%B8%8A%E5%8E%9F%2C+%E6%AD%A3%E5%BC%98&rft.au=%E9%A6%AC%E5%A0%B4%2C+%E6%85%8E%E5%8F%B8&rft.date=2008&rft.pub=%E6%97%A5%E6%9C%AC%E8%87%A8%E5%BA%8A%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=1345-2843&rft.eissn=1882-5133&rft.volume=69&rft.issue=11&rft.spage=2952&rft.epage=2955&rft_id=info:doi/10.3919%2Fjjsa.69.2952&rft.externalDocID=article_jjsa_69_11_69_11_2952_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1345-2843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1345-2843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1345-2843&client=summon